| Q43245106 | A model for chronic mucosal inflammation in IBD and periodontitis |
| Q37315879 | A novel model for studying ileitis-induced visceral hypersensitivity in goats |
| Q33862916 | A novel murine model for chronic inflammatory alveolar bone loss |
| Q33200059 | An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice |
| Q27495941 | Animal Models for Periodontal Disease |
| Q35647064 | Attenuation of Colitis by Serum-Derived Bovine Immunoglobulin/Protein Isolate in a Defined Microbiota Mouse Model |
| Q40214318 | Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice. |
| Q33662142 | Characterization of housing-related spontaneous variations of gut microbiota and expression of toll-like receptors 2 and 4 in rats |
| Q40563433 | Compromised neuroimmune status in rats with experimental colitis. |
| Q34006798 | Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice |
| Q34513599 | Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis |
| Q39613039 | Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. |
| Q84078756 | Effects of Bifidobacterium infantis 35624 on post-inflammatory visceral hypersensitivity in the rat |
| Q54423059 | Effects of monocolonization with Escherichia coli strains O6K13 and Nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficient mice. |
| Q37283648 | Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease |
| Q34300900 | Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia |
| Q55001002 | From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation. |
| Q35020376 | Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice |
| Q35595154 | Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria |
| Q46625014 | Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis |
| Q37203835 | Melatonin reduces bacterial translocation and apoptosis in trinitrobenzene sulphonic acid-induced colitis of rats |
| Q35597617 | Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid |
| Q34102357 | Ozone enema: a model of microscopic colitis in rats |
| Q63727118 | Pathobionts Associated with Inflammatory Bowel Disease |
| Q57241177 | Polyethylene glycol enhances colonic barrier function and ameliorates experimental colitis in rats |
| Q43980790 | Porcine ileitis model induced by TNBS-ethanol instillation |
| Q35059717 | Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. |
| Q81809212 | Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells |
| Q34637436 | Probiotics in the gastrointestinal diseases of the elderly. |
| Q36376117 | Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation |
| Q73629598 | Therapeutic role for bismuth compounds in TNBS-induced colitis in the rat |
| Q35140083 | Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria |